Overview

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

Status:
Terminated
Trial end date:
2018-12-10
Target enrollment:
Participant gender:
Summary
This is a Phase 3, multicenter, randomized, masked, controlled, parallel group study of 12 months duration in treatment naïve subjects with RVO.
Phase:
Phase 3
Details
Lead Sponsor:
Clearside Biomedical, Inc.
Treatments:
Aflibercept
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide